Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.07 USD | -0.54% | +2.24% | +0.55% |
10:21am | UBS Group to Redeem Senior Unsecured Notes Due 2025 | MT |
07-15 | Swiss Parliamentary Commission Formulates Statement of Facts on Credit Suisse Collapse | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The firm trades with high earnings multiples: 29.12 times its 2024 earnings per share.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.55% | 100B | - | ||
+1.37% | 122B | A- | ||
+18.57% | 71.5B | - | B+ | |
+29.35% | 69.7B | C | ||
+26.24% | 48.49B | C+ | ||
+17.37% | 44.28B | A- | ||
+26.22% | 38.4B | A- | ||
+10.26% | 26.51B | B | ||
+1.91% | 23.78B | A- | ||
+9.42% | 20.18B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- UBSG Stock
- UBS Stock
- Ratings UBS Group AG